CITIUS ONCOLOGY INC(CTOR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CTOR CITIUS ONCOLOGY INC

Trading 11-14 11:33:55 EST

1.13

-0.09

-7.38%

High1.18	Low1.10	Vol44.91K
Open1.18	D1 Closing1.22	Amplitude6.56%
Mkt Cap80.57M	Tradable Cap5.94M	Total Shares71.30M
T/O50.99K	T/O Rate0.85%	Tradable Shares5.25M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CTOR","market":"US","secType":"STK","nameCN":"CITIUS ONCOLOGY INC","latestPrice":1.13,"timestamp":1731601829617,"preClose":1.22,"halted":0,"volume":44912,"delay":0,"floatShares":5254400,"shares":71304049,"eps":-0.289236,"marketStatus":"Trading","change":-0.09,"latestTime":"11-14 11:33:55 EST","open":1.18,"high":1.18,"low":1.1,"amount":50991.095198400006,"amplitude":0.065574,"askPrice":1.15,"askSize":2649,"bidPrice":1.12,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.289236,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1731618000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.22,"preHourTrading":{"tag":"盘前","latestPrice":1.19,"preClose":1.22,"latestTime":"09:22 EST","volume":777,"amount":945.0660323999999,"timestamp":1731594140482},"postHourTrading":{"tag":"盘后","latestPrice":1.2,"preClose":1.22,"latestTime":"19:29 EST","volume":2058,"amount":2475.9976,"timestamp":1731544171239},"volumeRatio":0.881693},"requestUrl":"/m/hq/s/CTOR/wiki","defaultTab":"wiki","newsList":[{"id":"2482732197","title":"Citius Pharmaceuticals reports positive early stage results of cancer combo treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2482732197","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482732197?lang=en_us&edition=fundamental","pubTime":"2024-11-11 23:47","pubTimestamp":1731340063,"startTime":"0","endTime":"0","summary":"Citius Pharmaceuticals  and its subsidiary Citius Oncology  have reported positive early-stage results from an investigator-initiated clinical trial evaluating a combined regimen of LYMPHIR  and Keytruda , Merck’s  blockbuster","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4274423-citius-pharmaceuticals-reports-positive-early-stage-results-of-cancer-combo-treatment","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["BK4588","LU1934455863.HKD","LU1934455194.USD","LU1941712264.USD","IE00BSNM7G36.USD","LU0965509101.SGD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","LU1093756168.USD","BK4534","LU1023059063.AUD","PSQ","MNQmain","IE0009355771.USD","LU1917777945.USD","LU1116320737.USD","CTOR","LU0265550946.USD","LU0266013472.USD","LU0320765489.SGD","QID","LU0965509283.SGD","TQQQ","LU0861579265.USD","LU0122379950.USD","BK4516","SQQQ","BK4139","CTXR","LU1037948897.HKD","QLD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0965508806.USD","BK4559","LU0238689110.USD","LU1066051225.USD","MRK",".IXIC","LU0208291251.USD","LU0203345920.USD","LU1093756325.SGD","LU0203347892.USD","LU1037948541.HKD","LU0289739699.SGD","NQmain","LU1934455277.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2467759708","title":"Dr. Reddy's Agrees to Partial Deferral of Cancer Therapy-Related Milestone Payment by Citius Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2467759708","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467759708?lang=en_us&edition=fundamental","pubTime":"2024-09-14 00:14","pubTimestamp":1726244092,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK7016","BK4532","BK4557","BK4007","BK4139","RDY.AU","RDY","CTOR","BK4523"],"gpt_icon":0},{"id":"2467570871","title":"Dr. Reddy's Agrees to Partial Deferral of Cancer Therapy-Related Milestone Payment by Citius Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2467570871","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467570871?lang=en_us&edition=fundamental","pubTime":"2024-09-14 00:14","pubTimestamp":1726244092,"startTime":"0","endTime":"0","summary":"Citius Oncology  said Friday that Dr. Reddy's Laboratories  agreed to a partial deferral without penalty of a milestone payment by Citius that was triggered upon the US Food and Drug Administration's approval of the Lymphir cancer therapy.The milestone payment was due Sept. 9, Citius said in a filing with the US Securities and Exchange Commission.The company said that except for the partial deferral of the milestone payment, its September 2021 asset purchase agreement with Dr. Reddy's remains in full force and effect.CTOR shares were up 3.7% in recent Friday trading while RDY shares were climbing 0.4%.Price: 80.51, Change: +0.25, Percent Change: +0.32","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4557","BK4139","BK4007","RDY.AU","BK4523","BK4532","RDY","BK7016","CTOR"],"gpt_icon":0},{"id":"2460220148","title":"Citius Oncology Finalizes Merger and Modifies Stock Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2460220148","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2460220148?lang=en_us&edition=fundamental","pubTime":"2024-08-17 05:47","pubTimestamp":1723844858,"startTime":"0","endTime":"0","summary":"Citius Oncology (CTOR) just unveiled an update. On August 12, 2024, a notable business combination was finalized, leading to significant changes in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/citius-oncology-finalizes-merger-and-modifies-stock-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/citius-oncology-finalizes-merger-and-modifies-stock-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTOR"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0339},{"period":"1month","weight":0.1619},{"period":"3month","weight":-0.4578},{"period":"6month","weight":-0.891},{"period":"1year","weight":-0.8882},{"period":"ytd","weight":-0.8885}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.022},{"period":"3month","weight":0.0798},{"period":"6month","weight":0.1279},{"period":"1year","weight":0.3308},{"period":"ytd","weight":0.2564}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TenX Keane Acquisition focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on target businesses operating in Asia, excluding companies located or operating in mainland China, Hong Kong, or Macau. The company was incorporated in 2021 and is based in New York, New York.","exchange":"NASDAQ","name":"CITIUS ONCOLOGY INC","nameEN":"CITIUS ONCOLOGY INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CITIUS ONCOLOGY INC(CTOR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CITIUS ONCOLOGY INC(CTOR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CITIUS ONCOLOGY INC,CTOR,CITIUS ONCOLOGY INC股票,CITIUS ONCOLOGY INC股票老虎,CITIUS ONCOLOGY INC股票老虎国际,CITIUS ONCOLOGY INC行情,CITIUS ONCOLOGY INC股票行情,CITIUS ONCOLOGY INC股价,CITIUS ONCOLOGY INC股市,CITIUS ONCOLOGY INC股票价格,CITIUS ONCOLOGY INC股票交易,CITIUS ONCOLOGY INC股票购买,CITIUS ONCOLOGY INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CITIUS ONCOLOGY INC(CTOR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CITIUS ONCOLOGY INC(CTOR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction